 New high-volume production test allows Biomerica to expand international distribution to better meet demand of its 10-minute test for coronavirus exposure. Biomerica also announced it is now filling and has shipped commercial orders of its previously announced version of the product to Company distributors who are supplying customers that include NATO, and government agencies in Germany, Switzerland and the Netherlands. IRVINE, Calif., May 07, 2020 GLOBE NEWSWIRE -- Biomerica Inc. NASDAQ: BMRA today announced it has received a CE mark and launched a new high-volume production version of its COVID-19 IgGIgM Rapid Test a finger prick blood test with results in 10 minutes, that can be performed by trained professionals anywhere being sold in countries outside the US. 